New initiative aims to transform how Alzheimer’s disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer’s research, implementation science, and precision medicine.

Children with mitochondrial disorders have weaker antibody response to viral infections, study finds

In a new study, National Institutes of Health (NIH) researchers found that altered B cell function in children with mitochondrial disorders led to a weaker

July 7, 2023

GSK’s Ojjaara receives FDA approval for treating myelofibrosis patients with anaemia

The phase III MOMENTUM trial proved the drug’s efficiency. Credit: LindseyRN via Shutterstock. On 15 September 2023, the US Food and Drug Administration (FDA) approved

September 21, 2023

The Critical Importance of Payer-Provider Collaboration Goes Beyond Prior Authorization

Michael Drescher, Vice President of Payer Strategy, Xsolis The critical need to improve prior authorization processes might have reached its tipping point on Jan. 17. That’s

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.